Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus pneumoniae conserved surface protein epitopes are highly preserved antigenic regions found across the diverse serotypes of the S. pneumoniae bacterium. These epitopes are primarily located on essential virulence factors such as Pneumococcal surface protein A (PspA), Pneumococcal surface protein C (PspC), and Pneumococcal surface adhesin A (PsaA) (Ganaie et al., 2023). Their biological functions include facilitating bacterial attachment to host cells, inhibiting complement-mediated opsonization, and managing ion transport necessary for survival (Brooks & Mias, 2018). Because these proteins are conserved across nearly all pneumococcal strains, they serve as critical targets for next-generation, serotype-independent vaccines and monoclonal antibody therapies. In the context of disease, these targets are central to the pathogenesis of pneumonia, meningitis, and sepsis by allowing the bacteria to colonize the nasopharynx and disseminate into the bloodstream (Kadioglu et al., 2008). Therapeutic strategies focusing on these epitopes aim to elicit opsonophagocytic antibodies and neutralize the toxic effects of proteins like Pneumolysin. This approach addresses the limitations of current polysaccharide-based vaccines, which are susceptible to serotype replacement and provide narrower coverage (Astellas Pharma, 2021).
Induction of opsonophagocytic antibodies, neutralization of virulence factors, and inhibition of bacterial adhesion to host epithelial cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae conserved surface protein epitopes (Pneumococcal surface protein epitopes).